Menu
Back to Journals » Cancer Management and Research » Volume 11
Review
Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,722 | Dovepress* | 8,447+ | 1,298 | 9,745 | |
| PubMed Central* | 1,275 | 437 | 1,712 | ||
| Totals | 9,722 | 1,735 | 11,457 | ||
| *Since 4 January 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 1 | 0 | 0 | 3 | 4 |
View citations on PubMed and Google Scholar